已收盘 08-01 16:00:00 美东时间
-0.110
-9.73%
Orchestra BioMed Holdings, Inc. (NASDAQ:OBIO, "Orchestra BioMed" or the "Company"))), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, announced today that
08-01 04:03
During times of turbulence and uncertainty in the markets, many investors turn ...
07-21 19:46
2025年7月15日,华米科技单日暴涨46.29%,月内公司股价累计上涨395.86%,创下近三年以来新高。 (来源:wind) 引爆市场热情的,是公司在...
07-21 16:24
HeartBeam ( ($BEAT) ) has issued an update. On July 11, 2025, HeartBeam, Inc. h...
07-17 02:48
We model 2Q25 12% YoY topline contributed by solid 19% YoY music, both meeting ...
07-16 12:07
The investment landscape is shifting as companies show resilience and innovation, prompting investors to reassess portfolios. AbbVie, Boeing, Oracle, and Joby Aviation mentioned as potential opportunities.
07-11 19:53
AbbVie licensed IGI's trispecific myeloma drug ISB 2001 in a deal worth up to $1.925 billion following strong early-phase clinical data.
07-11 02:36
AbbVie (NYSE:ABBV) and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive licensing agreement for IGI's lead investigational asset, ISB
07-10 19:34
大公司: 消息称星巴克中国竞购估值或达100亿美元,近30家机构参与角逐 据三位知情人士透露,星巴克中国业务潜在股权出售已吸引多份报价,对该咖啡连锁品牌的估值最...
07-09 19:17